021-51111890
购物车（）
sales@molnova.cn
Ramucirumab
CAS No. 947687-13-0
Ramucirumab ( —— )
产品货号. M22160 CAS No. 947687-13-0
Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥4358 | 有现货 |
|
| 10MG | ￥6294 | 有现货 |
|
| 25MG | ￥9639 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ramucirumab
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors.
-
产品描述Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors.
-
同义词——
-
通路Angiogenesis
-
靶点VEGFR
-
受体VEGFR
-
研究领域——
-
适应症——
化学信息
-
CAS Number947687-13-0
-
分子量147 kDa
-
分子式——
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Fala L. Cyramza (Ramucirumab) Approved for the Treatment of Advanced Gastric Cancer and Metastatic Non-Small-Cell Lung Cancer. Am Health Drug Benefits. 2015 Mar;8(Spec Feature):49-53.
产品手册
关联产品
-
SU14813 maleate
A broad-spectrum RTKs inhibitor with IC50 ranging from 2 to 50 nM for VEGFR-1, VEGFR-2, PDGFRs, KIT, FLT3, and CSF1R/FMS.
-
AKB-6899
AKB-6899 is an inhibitor of prolyl hydroxylase domain 3 (PHD3) and increases the soluble form of the VEGF receptor (sVEGFR-1) production from GM-CSF-treated macrophages.
-
Vatalanib free base
A potent, orally available class III receptor tyrosine kinases inhibitor with IC50 of <1 uM for VEGFR, Flt-1, KDR and PDGFRβ.
